Covid-19: Novavax says vaccine shows 90% efficacy
This vaccine was scheduled for a September 2021 launch in India. The Indian government expects to get 20 crore doses of this vaccine from SII. US Vaccine maker Novavax on Monday said that its Covid dose demonstrated 90% overall efficacy and 100% protection against moderate and severe disease in Phase 3 trials. Novavax has a … Read more